Εμφάνιση απλής εγγραφής

dc.creatorKiropoulos, T. S.en
dc.creatorKostikas, K.en
dc.creatorOikonomidi, S.en
dc.creatorTsilioni, I.en
dc.creatorNikoulis, D.en
dc.creatorGermenis, A.en
dc.creatorGourgoulianis, K. I.en
dc.date.accessioned2015-11-23T10:34:55Z
dc.date.available2015-11-23T10:34:55Z
dc.date.issued2007
dc.identifier10.1016/j.rmed.2006.09.019
dc.identifier.issn9546111
dc.identifier.urihttp://hdl.handle.net/11615/29436
dc.description.abstractAcute-phase markers, such as C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α), have been studied in inflammatory and malignant disorders. We examined the diagnostic value of these markers for the differentiation among parapneumonic, tuberculous and malignant effusions. We studied 124 patients with pleural effusions, classified as exudates [total (n=97), parapneumonic (n=15), tuberculous (n=25), malignant (n=57)] and transudates due to congestive heart failure (n=27). CRP, IL-6 and TNF-α were measured in pleural fluid and serum. Pleural fluid CRP was higher in parapneumonic compared to tuberculous and malignant effusions, providing 100% sensitivity for a cut-off point of 5.3 mg/dL. IL-6 was higher in both parapneumonic and tuberculous compared to malignant effusions. TNF-α was higher in tuberculous compared to malignant effusions, providing 96.0% sensitivity, and 93.0% specificity for a cut-off point of 88.1 pg/mL. Pleural fluid CRP levels were lower than serum in all groups, probably reflecting systemic inflammation, whereas IL-6 and TNF-α were higher in pleural fluid indicating local production. Our data suggest that these markers may provide useful information for the differentiation of infectious and malignant effusions in clinical practice. However, further studies are needed for the validation of these findings in usual clinical circumstances. © 2006.en
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-33947719961&partnerID=40&md5=db07b92fe849c20bbb3d55d665acceac
dc.subjectAcute phase response markersen
dc.subjectC-reactive proteinen
dc.subjectInterleukin-6en
dc.subjectPleural effusionen
dc.subjectTumor necrosis factor alphaen
dc.subjectC reactive proteinen
dc.subjectinterleukin 6en
dc.subjectadulten
dc.subjectageden
dc.subjectarticleen
dc.subjectclinical practiceen
dc.subjectcongestive heart failureen
dc.subjectcontrolled studyen
dc.subjectcytokine productionen
dc.subjectdiagnostic valueen
dc.subjectdifferential diagnosisen
dc.subjectfemaleen
dc.subjecthumanen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectpleura canceren
dc.subjectpleura effusionen
dc.subjectpleura fluiden
dc.subjectpriority journalen
dc.subjectrespiratory tract inflammationen
dc.subjectsensitivity and specificityen
dc.subjectserumen
dc.subjecttuberculous pleurisyen
dc.subjectvalidation processen
dc.subjectAcute-Phase Proteinsen
dc.subjectAged, 80 and overen
dc.subjectBiological Markersen
dc.subjectDiagnosis, Differentialen
dc.subjectEpidemiologic Methodsen
dc.subjectExudates and Transudatesen
dc.subjectHumansen
dc.subjectMiddle Ageden
dc.subjectPleural Effusion, Malignanten
dc.subjectPneumonia, Bacterialen
dc.subjectTuberculosis, Pleuralen
dc.subjectTumor Necrosis Factor-alphaen
dc.titleAcute phase markers for the differentiation of infectious and malignant pleural effusionsen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής